Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (5): 831-832    DOI: 10.12891/ceog4808.2019
Case Report Previous articles | Next articles
Pulmonary lymphangioleiomyomatosis as an uncommon cause of recurrent early pregnancy loss
E.H. Comert1, H. Sal1, E.S. Guvendag Guven1, S. Guven1, *()
1Department of Obstetrics and Gynecology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey
Download:  PDF(426KB)  ( 188 ) Full text   ( 4 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Pulmonary lymphangioleimyomatosis (LAM) is a rare disorder characterized by hamartomatous proliferation of smooth muscle within lung parenchyma. LAM occurs only in women and exacerbates with menstruation, estrogen use, and taking oral contraceptives. The effect of pulmonary LAM on recurrent pregnancy loss has not been reported previously. A 28-years-old (gravida 2 parity 0 abortion 2) woman was admitted to the gynecology outpatient clinic because of habitual abortion. The patient had a history of early (one 8-week and another 6-week) pregnancy losses. CT scan showed widespread and varied dimension thin edge cystic lesions extending to about 1 cm in diameter of the largest size observed in all segments of both lungs. All other recurrent pregnancy loss tests were within normal limits, except pulmonary LAM findings on CT scan. Clinicians should keep in mind the diagnosis of pulmonary LAM, in cases with progressive dyspnea (especially in luteal phase of menstruation) and recurrent pregnancy losses.

Key words:  Fibronectin      Habitual abortion      Invasion      Pulmonary lymphangioleiomyomatosis     
Published:  10 October 2019     
*Corresponding Author(s):  S. GUVEN     E-mail:  drsuleymanguven@yahoo.com

Cite this article: 

E.H. Comert, H. Sal, E.S. Guvendag Guven, S. Guven. Pulmonary lymphangioleiomyomatosis as an uncommon cause of recurrent early pregnancy loss. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 831-832.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4808.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I5/831

[1] G.-Y. Xia, Q.-Q. Fu, H.-M. Li, M. Fang, T. Zhang, M.-W. Wu, L.-M. Chen, C.-Y. Wu, B. Yu, H.-T. Pan, X.-L. Shi. Downregulation of Hsp27 inhibits proliferation, migration and invasion in human choriocarcinoma cell line JAR[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 245-249.
[2] C.E. Bedient, D. Rodriguez, N. Sidell, C. Roberts, S.C. Schutte. Alterations in the invasive properties of peripheral blood monocytes from patients with endometriosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 60-65.
[3] Manchao Li, Baozhi Wang, Zhiming He, Yi Zhou, Qun Fang. Downregulated osteopontin in placenta affects MMPs expression of trophoblastic cells[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 558-562.
[4] T. Tsunemi, T. Sado, K. Naruse, H. Kobayashi. Paternal contribution to the preeclampsia phenotype[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 914-922.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .